PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
45.68
ESG score below 80% of EXEL's 62.63. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
50.00
Environmental score 90-95% of EXEL's 53.09. Bill Ackman would demand clear environmental improvement catalysts.
39.02
Social score below 80% of EXEL's 67.03. Jim Chanos would check for potential social license and litigation risks.
48.01
Governance score below 80% of EXEL's 67.78. Jim Chanos would check for potential agency conflicts and oversight failures.